Nicotine-like Drug in Schizophrenia Treatment
An experimental drug that acts on the same parts of the brain as nicotine is showing promise in helping people with schizophrenia, researchers say. In animal trials, the new drug showed a range of beneficial effects; most notably improved thinking ability.
Although advances have been made in the treatment of schizophrenic symptoms such as delusions and withdrawal and apathy, problems with attention and thinking processes persist. According to the researchers, this drug was tested due to a hypothesis that the heavy rates of smoking among schizophrenics (seen in 80% of all cases) might be a form of self medication.